137 related articles for article (PubMed ID: 12878219)
1. Reversible inhibition of the human xenobiotic-metabolizing enzyme arylamine N-acetyltransferase 1 by S-nitrosothiols.
Dairou J; Atmane N; Dupret JM; Rodrigues-Lima F
Biochem Biophys Res Commun; 2003 Aug; 307(4):1059-65. PubMed ID: 12878219
[TBL] [Abstract][Full Text] [Related]
2. Redox regulation of the human xenobiotic metabolizing enzyme arylamine N-acetyltransferase 1 (NAT1). Reversible inactivation by hydrogen peroxide.
Atmane N; Dairou J; Paul A; Dupret JM; Rodrigues-Lima F
J Biol Chem; 2003 Sep; 278(37):35086-92. PubMed ID: 12832400
[TBL] [Abstract][Full Text] [Related]
3. Identification of the xenobiotic-metabolizing enzyme arylamine N-acetyltransferase 1 as a new target of cisplatin in breast cancer cells: molecular and cellular mechanisms of inhibition.
Ragunathan N; Dairou J; Pluvinage B; Martins M; Petit E; Janel N; Dupret JM; Rodrigues-Lima F
Mol Pharmacol; 2008 Jun; 73(6):1761-8. PubMed ID: 18310302
[TBL] [Abstract][Full Text] [Related]
4. Peroxynitrite irreversibly inactivates the human xenobiotic-metabolizing enzyme arylamine N-acetyltransferase 1 (NAT1) in human breast cancer cells: a cellular and mechanistic study.
Dairou J; Atmane N; Rodrigues-Lima F; Dupret JM
J Biol Chem; 2004 Feb; 279(9):7708-14. PubMed ID: 14672957
[TBL] [Abstract][Full Text] [Related]
5. Structure and regulation of the drug-metabolizing enzymes arylamine N-acetyltransferases.
Dupret JM; Rodrigues-Lima F
Curr Med Chem; 2005; 12(3):311-8. PubMed ID: 15723621
[TBL] [Abstract][Full Text] [Related]
6. The human xenobiotic-metabolizing enzyme arylamine N-acetyltransferase 1 (NAT1) is irreversibly inhibited by inorganic (Hg2+) and organic mercury (CH3Hg+): mechanism and kinetics.
Ragunathan N; Busi F; Pluvinage B; Sanfins E; Dupret JM; Rodrigues-Lima F; Dairou J
FEBS Lett; 2010 Aug; 584(15):3366-9. PubMed ID: 20591428
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of papain by S-nitrosothiols. Formation of mixed disulfides.
Xian M; Chen X; Liu Z; Wang K; Wang PG
J Biol Chem; 2000 Jul; 275(27):20467-73. PubMed ID: 10779505
[TBL] [Abstract][Full Text] [Related]
8. Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases.
Hein DW; Doll MA; Rustan TD; Gray K; Feng Y; Ferguson RJ; Grant DM
Carcinogenesis; 1993 Aug; 14(8):1633-8. PubMed ID: 8353847
[TBL] [Abstract][Full Text] [Related]
9. Human arylamine N-acetyltransferase 1: a drug-metabolizing enzyme and a drug target?
Rodrigues-Lima F; Dairou J; Busi F; Dupret JM
Curr Drug Targets; 2010 Jun; 11(6):759-66. PubMed ID: 20041842
[TBL] [Abstract][Full Text] [Related]
10. Human arylamine N-acetyltransferase 1: in vitro and intracellular inactivation by nitrosoarene metabolites of toxic and carcinogenic arylamines.
Liu L; Wagner CR; Hanna PE
Chem Res Toxicol; 2008 Oct; 21(10):2005-16. PubMed ID: 18759501
[TBL] [Abstract][Full Text] [Related]
11. Isoform-selective inactivation of human arylamine N-acetyltransferases by reactive metabolites of carcinogenic arylamines.
Liu L; Wagner CR; Hanna PE
Chem Res Toxicol; 2009 Dec; 22(12):1962-74. PubMed ID: 19842618
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms and kinetics of human arylamine N-acetyltransferase 1 inhibition by disulfiram.
Malka F; Dairou J; Ragunathan N; Dupret JM; Rodrigues-Lima F
FEBS J; 2009 Sep; 276(17):4900-8. PubMed ID: 19664055
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory cytokines suppress arylamine N-acetyltransferase 1 in cholangiocarcinoma cells.
Buranrat B; Prawan A; Sripa B; Kukongviriyapan V
World J Gastroenterol; 2007 Dec; 13(46):6219-25. PubMed ID: 18069763
[TBL] [Abstract][Full Text] [Related]
14. Probing the mechanism of hamster arylamine N-acetyltransferase 2 acetylation by active site modification, site-directed mutagenesis, and pre-steady state and steady state kinetic studies.
Wang H; Vath GM; Gleason KJ; Hanna PE; Wagner CR
Biochemistry; 2004 Jun; 43(25):8234-46. PubMed ID: 15209520
[TBL] [Abstract][Full Text] [Related]
15. Impairment of the activity of the xenobiotic-metabolizing enzymes arylamine N-acetyltransferases 1 and 2 (NAT1/NAT2) by peroxynitrite in mouse skeletal muscle cells.
Dairou J; Dupret JM; Rodrigues-Lima F
FEBS Lett; 2005 Aug; 579(21):4719-23. PubMed ID: 16098511
[TBL] [Abstract][Full Text] [Related]
16. Regulation of the activity of the human drug metabolizing enzyme arylamine N-acetyltransferase 1: role of genetic and non genetic factors.
Rodrigues-Lima F; Dupret JM
Curr Pharm Des; 2004; 10(20):2519-24. PubMed ID: 15320760
[TBL] [Abstract][Full Text] [Related]
17. Cadmium alters the biotransformation of carcinogenic aromatic amines by arylamine N-acetyltransferase xenobiotic-metabolizing enzymes: molecular, cellular, and in vivo studies.
Ragunathan N; Dairou J; Sanfins E; Busi F; Noll C; Janel N; Dupret JM; Rodrigues-Lima F
Environ Health Perspect; 2010 Dec; 118(12):1685-91. PubMed ID: 20810355
[TBL] [Abstract][Full Text] [Related]
18. Inactivation of human arylamine N-acetyltransferase 1 by the hydroxylamine of p-aminobenzoic acid.
Butcher NJ; Ilett KF; Minchin RF
Biochem Pharmacol; 2000 Dec; 60(12):1829-36. PubMed ID: 11108798
[TBL] [Abstract][Full Text] [Related]
19. Structural and kinetic modifications of aldose reductase by S-nitrosothiols.
Srivastava S; Dixit BL; Ramana KV; Chandra A; Chandra D; Zacarias A; Petrash JM; Bhatnagar A; Srivastava SK
Biochem J; 2001 Aug; 358(Pt 1):111-8. PubMed ID: 11485558
[TBL] [Abstract][Full Text] [Related]
20. The xenobiotic-metabolizing enzymes arylamine N-acetyltransferases in human lens epithelial cells: inactivation by cellular oxidants and UVB-induced oxidative stress.
Dairou J; Malecaze F; Dupret JM; Rodrigues-Lima F
Mol Pharmacol; 2005 Apr; 67(4):1299-306. PubMed ID: 15644493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]